Exact Mass: 803.6427

Exact Mass Matches: 803.6427

Found 233 metabolites which its exact mass value is equals to given mass value 803.6427, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PC(15:0/22:0)

(2-{[(2R)-2-(docosanoyloxy)-3-(pentadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C45H90NO8P (803.6404)


PC(15:0/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/22:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of behenic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(15:0/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/22:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of behenic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(22:0/15:0)

(2-{[(2R)-3-(docosanoyloxy)-2-(pentadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C45H90NO8P (803.6404)


PC(22:0/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/15:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(22:0/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/15:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(16:0/24:0)

(2-aminoethoxy)[(2R)-3-(hexadecanoyloxy)-2-(tetracosanoyloxy)propoxy]phosphinic acid

C45H90NO8P (803.6404)


PE(16:0/24:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:0/24:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(16:0/24:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(16:0/24:0), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one tetracosanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(18:0/22:0)

(2-aminoethoxy)[(2R)-2-(docosanoyloxy)-3-(octadecanoyloxy)propoxy]phosphinic acid

C45H90NO8P (803.6404)


PE(18:0/22:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:0/22:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of behenic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(18:0/22:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:0/22:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of behenic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(20:0/20:0)

(2-aminoethoxy)[(2R)-2,3-bis(icosanoyloxy)propoxy]phosphinic acid

C45H90NO8P (803.6404)


PE(20:0/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:0/20:0), in particular, consists of two chains of arachidic acid at the C-1 and C-2 positions. The arachidic acid moieties are derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(20:0/20:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PE(20:0/20:0), in particular, consists of two eicosanoyl chains at positions C-1 and C-2. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(22:0/18:0)

(2-aminoethoxy)[(2R)-3-(docosanoyloxy)-2-(octadecanoyloxy)propoxy]phosphinic acid

C45H90NO8P (803.6404)


PE(22:0/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:0/18:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of stearic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(22:0/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:0/18:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of stearic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(24:0/16:0)

(2-aminoethoxy)[(2R)-2-(hexadecanoyloxy)-3-(tetracosanoyloxy)propoxy]phosphinic acid

C45H90NO8P (803.6404)


PE(24:0/16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:0/16:0), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of palmitic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(24:0/16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:0/16:0), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of palmitic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(15:0/24:0)

[2-(methylamino)ethoxy][3-(pentadecanoyloxy)-2-(tetracosanoyloxy)propoxy]phosphinic acid

C45H90NO8P (803.6404)


PE-NMe(15:0/24:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(15:0/24:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(24:0/15:0)

[2-(methylamino)ethoxy][2-(pentadecanoyloxy)-3-(tetracosanoyloxy)propoxy]phosphinic acid

C45H90NO8P (803.6404)


PE-NMe(24:0/15:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(24:0/15:0), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(14:0/24:0)

[2-(dimethylamino)ethoxy][2-(tetracosanoyloxy)-3-(tetradecanoyloxy)propoxy]phosphinic acid

C45H90NO8P (803.6404)


PE-NMe2(14:0/24:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(14:0/24:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(16:0/22:0)

[2-(dimethylamino)ethoxy][2-(docosanoyloxy)-3-(hexadecanoyloxy)propoxy]phosphinic acid

C45H90NO8P (803.6404)


PE-NMe2(16:0/22:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(16:0/22:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(18:0/20:0)

[2-(dimethylamino)ethoxy][2-(icosanoyloxy)-3-(octadecanoyloxy)propoxy]phosphinic acid

C45H90NO8P (803.6404)


PE-NMe2(18:0/20:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:0/20:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(20:0/18:0)

[2-(dimethylamino)ethoxy][3-(icosanoyloxy)-2-(octadecanoyloxy)propoxy]phosphinic acid

C45H90NO8P (803.6404)


PE-NMe2(20:0/18:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:0/18:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of stearic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(22:0/16:0)

[2-(dimethylamino)ethoxy][3-(docosanoyloxy)-2-(hexadecanoyloxy)propoxy]phosphinic acid

C45H90NO8P (803.6404)


PE-NMe2(22:0/16:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:0/16:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(24:0/14:0)

[2-(dimethylamino)ethoxy][3-(tetracosanoyloxy)-2-(tetradecanoyloxy)propoxy]phosphinic acid

C45H90NO8P (803.6404)


PE-NMe2(24:0/14:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(24:0/14:0), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

CE-3-2

(2S,3R,4R)-1-O-(beta-D-glucopyranosyl)-2-[(2R)-2-hydroxydocosanoylamino]-14-methylhexadecan-3,4-diol

C45H89NO10 (803.6486)


   
   
   

PC(13:0/24:0)[U]

3,5,8-Trioxa-4-phosphadotriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxotridecyl)oxy]methyl]-, inner salt, 4-oxide

C45H90NO8P (803.6404)


   

PC(14:0/23:0)[U]

3,5,8-Trioxa-4-phosphahentriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxotetradecyl)oxy]methyl]-, inner salt, 4-oxide

C45H90NO8P (803.6404)


   

PC(15:0/22:0)[U]

1-Pentadecanoyl-2-docosanoyl-sn-glycero-3-phosphocholine

C45H90NO8P (803.6404)


   

PC(16:0/21:0)[U]

3,5,8-Trioxa-4-phosphanonacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxohexadecyl)oxy]methyl]-, inner salt, 4-oxide

C45H90NO8P (803.6404)


   

PC(17:0/20:0)[U]

3,5,8-Trioxa-4-phosphaoctacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxoheptadecyl)oxy]methyl]-, inner salt, 4-oxide

C45H90NO8P (803.6404)


   

PC(18:0/19:0)[U]

3,5,8-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxooctadecyl)oxy]methyl]-, inner salt, 4-oxide

C45H90NO8P (803.6404)


   

PC(19:0/18:0)

3,5,9-Trioxa-4-phosphaoctacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxooctadecyl)oxy]-, inner salt, 4-oxide, (R)-

C45H90NO8P (803.6404)


   

PC(20:0/17:0)[U]

3,5,9-Trioxa-4-phosphanonacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxoheptadecyl)oxy]-, inner salt, 4-oxide

C45H90NO8P (803.6404)


   

PC(21:0/16:0)[U]

3,5,9-Trioxa-4-phosphatriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxohexadecyl)oxy]-, inner salt, 4-oxide

C45H90NO8P (803.6404)


   

PC(23:0/14:0)[U]

3,5,9-Trioxa-4-phosphadotriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxotetradecyl)oxy]-, inner salt, 4-oxide

C45H90NO8P (803.6404)


   

PC(24:0/13:0)[U]

3,5,9-Trioxa-4-phosphatritriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxotridecyl)oxy]-, inner salt, 4-oxide

C45H90NO8P (803.6404)


   

PC(25:0/12:0)[U]

3,5,9-Trioxa-4-phosphatetratriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxododecyl)oxy]-, inner salt, 4-oxide

C45H90NO8P (803.6404)


   

PC(26:0/11:0)[U]

3,5,9-Trioxa-4-phosphapentatriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxoundecyl)oxy]-, inner salt, 4-oxide

C45H90NO8P (803.6404)


   

PE(20:0/20:0)[U]

1,2-dieicosanoyl-sn-glycero-3-phosphoethanolamine

C45H90NO8P (803.6404)


   

PE(19:0/21:0)[U]

Heneicosanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxononadecyl)oxy]ethyl ester

C45H90NO8P (803.6404)


   

PE(18:0/22:0)

Docosanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxooctadecyl)oxy]ethyl ester, (R)-

C45H90NO8P (803.6404)


   

PE(18:0/22:0)[U]

Docosanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxooctadecyl)oxy]ethyl ester

C45H90NO8P (803.6404)


   

PE(21:0/19:0)[U]

1-heneicosanoyl-2-nonadecanoyl-sn-glycero-3-phosphoethanolamine

C45H90NO8P (803.6404)


   

PE(23:0/17:0)[U]

1-tricosanoyl-2-heptadecanoyl-sn-glycero-3-phosphoethanolamine

C45H90NO8P (803.6404)


   

PE(22:0/18:0)[U]

1-Docosanoyl-2-octadecanoyl-sn-glycero-3-phosphoethanolamine

C45H90NO8P (803.6404)


   

PE(17:0/23:0)[U]

1-heptadecanoyl-2-tricosanoyl-sn-glycero-3-phosphoethanolamine

C45H90NO8P (803.6404)


   

PE(16:0/24:0)[U]

1-Hexadecanoyl-2-tetracosanoyl-sn-glycero-3-phosphoethanolamine

C45H90NO8P (803.6404)


   

PE(15:0/25:0)[U]

1-pentadecanoyl-2-pentacosanoyl-sn-glycero-3-phosphoethanolamine

C45H90NO8P (803.6404)


   

Lecithin

1-behenoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C45H90NO8P (803.6404)


   

PE(40:0)

1-Lignoceroyl-2-palmitoyl-sn-glycero-3-phosphoethanolamine

C45H90NO8P (803.6404)


   

PC(16:0/21:0)

1-hexadecanoyl-2-heneicosanoyl-glycero-3-phosphocholine

C45H90NO8P (803.6404)


   

PC(17:0/20:0)

1-heptadecanoyl-2-eicosanoyl-glycero-3-phosphocholine

C45H90NO8P (803.6404)


   

PC(18:0/19:0)

1-octadecanoyl-2-nonadecanoyl-glycero-3-phosphocholine

C45H90NO8P (803.6404)


   

PC(20:0/17:0)

1-eicosanoyl-2-heptadecanoyl-glycero-3-phosphocholine

C45H90NO8P (803.6404)


   

PC(21:0/16:0)

1-heneicosanoyl-2-hexadecanoyl-glycero-3-phosphocholine

C45H90NO8P (803.6404)


   

PE(19:0/21:0)

1-nonadecanoyl-2-heneicosanoyl-glycero-3-phosphoethanolamine

C45H90NO8P (803.6404)


   

PE(21:0/19:0)

1-heneicosanoyl-2-nonadecanoyl-glycero-3-phosphoethanolamine

C45H90NO8P (803.6404)


   

PC 37:0

1-nonadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine

C45H90NO8P (803.6404)


   

PE 40:0

Docosanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxooctadecyl)oxy]ethyl ester, (R)-

C45H90NO8P (803.6404)


   

HexCer 39:0;O4

N-(2R-hydroxyheneicosanoyl)-1-beta-glucopyranosyl-4R-hydroxy-16-methyl-heptadecasphinganine

C45H89NO10 (803.6486)


   

(R)-1-((((2-Aminoethoxy)hydroxyphosphinyl)oxy)methyl)ethylene diicosanoate

(R)-1-((((2-Aminoethoxy)hydroxyphosphinyl)oxy)methyl)ethylene diicosanoate

C45H90NO8P (803.6404)


   

HexCer 16:0;3O/23:0;(2OH)

HexCer 16:0;3O/23:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 17:0;3O/22:0;(2OH)

HexCer 17:0;3O/22:0;(2OH)

C45H89NO10 (803.6486)


   

N-(2-hydroxydocosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine

N-(2-hydroxydocosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine

C45H89NO10 (803.6486)


   

(2-Hexacosanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hexacosanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

(3-Heptadecanoyloxy-2-icosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Heptadecanoyloxy-2-icosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

7-[(Dodecanoyloxy)methyl]-4-hydroxy-N,N,N-trimethyl-9-oxo-3,5,8-trioxa-4-phosphadotriacontan-1-aminium 4-oxide

7-[(Dodecanoyloxy)methyl]-4-hydroxy-N,N,N-trimethyl-9-oxo-3,5,8-trioxa-4-phosphadotriacontan-1-aminium 4-oxide

C45H90NO8P (803.6404)


   

NAGly 24:4/26:4

NAGly 24:4/26:4

C52H85NO5 (803.6427)


   

NAGly 26:7/24:1

NAGly 26:7/24:1

C52H85NO5 (803.6427)


   

NAGly 24:6/26:2

NAGly 24:6/26:2

C52H85NO5 (803.6427)


   

NAGly 26:4/24:4

NAGly 26:4/24:4

C52H85NO5 (803.6427)


   

NAGly 26:6/24:2

NAGly 26:6/24:2

C52H85NO5 (803.6427)


   

Lnape 24:0/N-16:0

Lnape 24:0/N-16:0

C45H90NO8P (803.6404)


   

Lnape 20:0/N-20:0

Lnape 20:0/N-20:0

C45H90NO8P (803.6404)


   

Lnape 25:0/N-15:0

Lnape 25:0/N-15:0

C45H90NO8P (803.6404)


   

Lnape 27:0/N-13:0

Lnape 27:0/N-13:0

C45H90NO8P (803.6404)


   

Lnape 23:0/N-17:0

Lnape 23:0/N-17:0

C45H90NO8P (803.6404)


   

Lnape 18:0/N-22:0

Lnape 18:0/N-22:0

C45H90NO8P (803.6404)


   

Lnape 16:0/N-24:0

Lnape 16:0/N-24:0

C45H90NO8P (803.6404)


   

Lnape 14:0/N-26:0

Lnape 14:0/N-26:0

C45H90NO8P (803.6404)


   

Lnape 13:0/N-27:0

Lnape 13:0/N-27:0

C45H90NO8P (803.6404)


   

Lnape 17:0/N-23:0

Lnape 17:0/N-23:0

C45H90NO8P (803.6404)


   

Lnape 19:0/N-21:0

Lnape 19:0/N-21:0

C45H90NO8P (803.6404)


   

Lnape 22:0/N-18:0

Lnape 22:0/N-18:0

C45H90NO8P (803.6404)


   

Lnape 15:0/N-25:0

Lnape 15:0/N-25:0

C45H90NO8P (803.6404)


   

Lnape 21:0/N-19:0

Lnape 21:0/N-19:0

C45H90NO8P (803.6404)


   

Lnape 26:0/N-14:0

Lnape 26:0/N-14:0

C45H90NO8P (803.6404)


   

HexCer 9:0;3O/30:0;(2OH)

HexCer 9:0;3O/30:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 8:0;3O/31:0;(2OH)

HexCer 8:0;3O/31:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 11:0;3O/28:0;(2OH)

HexCer 11:0;3O/28:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 10:0;3O/29:0;(2OH)

HexCer 10:0;3O/29:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 13:0;3O/26:0;(2OH)

HexCer 13:0;3O/26:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 12:0;3O/27:0;(2OH)

HexCer 12:0;3O/27:0;(2OH)

C45H89NO10 (803.6486)


   

2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxytricosane-1-sulfonic acid

2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxytricosane-1-sulfonic acid

C49H89NO5S (803.6461)


   

3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]pentacosane-1-sulfonic acid

3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]pentacosane-1-sulfonic acid

C49H89NO5S (803.6461)


   

(4E,8E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxytricosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxytricosa-4,8-diene-1-sulfonic acid

C49H89NO5S (803.6461)


   

(4E,8E,12E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxytricosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxytricosa-4,8,12-triene-1-sulfonic acid

C49H89NO5S (803.6461)


   

(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]pentacosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]pentacosa-4,8,12-triene-1-sulfonic acid

C49H89NO5S (803.6461)


   

(E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxytricos-4-ene-1-sulfonic acid

(E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxytricos-4-ene-1-sulfonic acid

C49H89NO5S (803.6461)


   

(E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]pentacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]pentacos-4-ene-1-sulfonic acid

C49H89NO5S (803.6461)


   

(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]pentacosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]pentacosa-4,8-diene-1-sulfonic acid

C49H89NO5S (803.6461)


   

2-[4-[3-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

2-[4-[3-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C52H85NO5 (803.6427)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] hentriacontanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] hentriacontanoate

C45H90NO8P (803.6404)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] octacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] octacosanoate

C45H90NO8P (803.6404)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] triacontanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] triacontanoate

C45H90NO8P (803.6404)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] nonacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] nonacosanoate

C45H90NO8P (803.6404)


   

Cer 16:0;2O/20:4;(3OH)(FA 16:5)

Cer 16:0;2O/20:4;(3OH)(FA 16:5)

C52H85NO5 (803.6427)


   

Cer 14:0;2O/22:4;(3OH)(FA 16:5)

Cer 14:0;2O/22:4;(3OH)(FA 16:5)

C52H85NO5 (803.6427)


   

Cer 16:0;2O/16:4;(3OH)(FA 20:5)

Cer 16:0;2O/16:4;(3OH)(FA 20:5)

C52H85NO5 (803.6427)


   

Cer 15:0;2O/21:5;(3OH)(FA 16:4)

Cer 15:0;2O/21:5;(3OH)(FA 16:4)

C52H85NO5 (803.6427)


   

Cer 15:0;2O/21:4;(3OH)(FA 16:5)

Cer 15:0;2O/21:4;(3OH)(FA 16:5)

C52H85NO5 (803.6427)


   

Cer 14:0;2O/22:6;(3OH)(FA 16:3)

Cer 14:0;2O/22:6;(3OH)(FA 16:3)

C52H85NO5 (803.6427)


   

Cer 14:0;2O/19:5;(3OH)(FA 19:4)

Cer 14:0;2O/19:5;(3OH)(FA 19:4)

C52H85NO5 (803.6427)


   

Cer 14:0;2O/18:4;(3OH)(FA 20:5)

Cer 14:0;2O/18:4;(3OH)(FA 20:5)

C52H85NO5 (803.6427)


   

Cer 15:0;2O/18:5;(3OH)(FA 19:4)

Cer 15:0;2O/18:5;(3OH)(FA 19:4)

C52H85NO5 (803.6427)


   

Cer 20:0;2O/16:5;(3OH)(FA 16:4)

Cer 20:0;2O/16:5;(3OH)(FA 16:4)

C52H85NO5 (803.6427)


   

Cer 14:0;2O/19:4;(3OH)(FA 19:5)

Cer 14:0;2O/19:4;(3OH)(FA 19:5)

C52H85NO5 (803.6427)


   

Cer 16:0;2O/16:5;(3OH)(FA 20:4)

Cer 16:0;2O/16:5;(3OH)(FA 20:4)

C52H85NO5 (803.6427)


   

Cer 16:0;2O/20:5;(3OH)(FA 16:4)

Cer 16:0;2O/20:5;(3OH)(FA 16:4)

C52H85NO5 (803.6427)


   

Cer 16:0;2O/20:6;(3OH)(FA 16:3)

Cer 16:0;2O/20:6;(3OH)(FA 16:3)

C52H85NO5 (803.6427)


   

Cer 14:0;2O/20:6;(3OH)(FA 18:3)

Cer 14:0;2O/20:6;(3OH)(FA 18:3)

C52H85NO5 (803.6427)


   

Cer 18:0;2O/16:5;(3OH)(FA 18:4)

Cer 18:0;2O/16:5;(3OH)(FA 18:4)

C52H85NO5 (803.6427)


   

Cer 18:0;2O/16:4;(3OH)(FA 18:5)

Cer 18:0;2O/16:4;(3OH)(FA 18:5)

C52H85NO5 (803.6427)


   

Cer 18:0;2O/18:4;(3OH)(FA 16:5)

Cer 18:0;2O/18:4;(3OH)(FA 16:5)

C52H85NO5 (803.6427)


   

Cer 15:0;2O/17:3;(3OH)(FA 20:6)

Cer 15:0;2O/17:3;(3OH)(FA 20:6)

C52H85NO5 (803.6427)


   

Cer 17:0;2O/16:4;(3OH)(FA 19:5)

Cer 17:0;2O/16:4;(3OH)(FA 19:5)

C52H85NO5 (803.6427)


   

Cer 15:0;2O/16:5;(3OH)(FA 21:4)

Cer 15:0;2O/16:5;(3OH)(FA 21:4)

C52H85NO5 (803.6427)


   

Cer 17:0;2O/19:4;(3OH)(FA 16:5)

Cer 17:0;2O/19:4;(3OH)(FA 16:5)

C52H85NO5 (803.6427)


   

Cer 15:0;2O/19:4;(3OH)(FA 18:5)

Cer 15:0;2O/19:4;(3OH)(FA 18:5)

C52H85NO5 (803.6427)


   

Cer 15:0;2O/16:4;(3OH)(FA 21:5)

Cer 15:0;2O/16:4;(3OH)(FA 21:5)

C52H85NO5 (803.6427)


   

Cer 14:0;2O/22:5;(3OH)(FA 16:4)

Cer 14:0;2O/22:5;(3OH)(FA 16:4)

C52H85NO5 (803.6427)


   

Cer 14:0;2O/18:5;(3OH)(FA 20:4)

Cer 14:0;2O/18:5;(3OH)(FA 20:4)

C52H85NO5 (803.6427)


   

Cer 15:0;2O/20:6;(3OH)(FA 17:3)

Cer 15:0;2O/20:6;(3OH)(FA 17:3)

C52H85NO5 (803.6427)


   

Cer 16:0;2O/18:4;(3OH)(FA 18:5)

Cer 16:0;2O/18:4;(3OH)(FA 18:5)

C52H85NO5 (803.6427)


   

Cer 14:0;2O/20:4;(3OH)(FA 18:5)

Cer 14:0;2O/20:4;(3OH)(FA 18:5)

C52H85NO5 (803.6427)


   

Cer 18:0;2O/18:5;(3OH)(FA 16:4)

Cer 18:0;2O/18:5;(3OH)(FA 16:4)

C52H85NO5 (803.6427)


   

Cer 16:0;2O/18:5;(3OH)(FA 18:4)

Cer 16:0;2O/18:5;(3OH)(FA 18:4)

C52H85NO5 (803.6427)


   

Cer 17:0;2O/19:5;(3OH)(FA 16:4)

Cer 17:0;2O/19:5;(3OH)(FA 16:4)

C52H85NO5 (803.6427)


   

Cer 14:0;2O/16:3;(3OH)(FA 22:6)

Cer 14:0;2O/16:3;(3OH)(FA 22:6)

C52H85NO5 (803.6427)


   

Cer 16:0;2O/16:3;(3OH)(FA 20:6)

Cer 16:0;2O/16:3;(3OH)(FA 20:6)

C52H85NO5 (803.6427)


   

Cer 14:0;2O/18:3;(3OH)(FA 20:6)

Cer 14:0;2O/18:3;(3OH)(FA 20:6)

C52H85NO5 (803.6427)


   

Cer 20:0;2O/16:4;(3OH)(FA 16:5)

Cer 20:0;2O/16:4;(3OH)(FA 16:5)

C52H85NO5 (803.6427)


   

Cer 15:0;2O/19:5;(3OH)(FA 18:4)

Cer 15:0;2O/19:5;(3OH)(FA 18:4)

C52H85NO5 (803.6427)


   

Cer 15:0;2O/18:4;(3OH)(FA 19:5)

Cer 15:0;2O/18:4;(3OH)(FA 19:5)

C52H85NO5 (803.6427)


   

Cer 17:0;2O/16:5;(3OH)(FA 19:4)

Cer 17:0;2O/16:5;(3OH)(FA 19:4)

C52H85NO5 (803.6427)


   

Cer 14:0;2O/20:5;(3OH)(FA 18:4)

Cer 14:0;2O/20:5;(3OH)(FA 18:4)

C52H85NO5 (803.6427)


   

Cer 14:0;2O/16:4;(3OH)(FA 22:5)

Cer 14:0;2O/16:4;(3OH)(FA 22:5)

C52H85NO5 (803.6427)


   

Cer 14:0;2O/16:5;(3OH)(FA 22:4)

Cer 14:0;2O/16:5;(3OH)(FA 22:4)

C52H85NO5 (803.6427)


   

HexCer 18:0;3O/21:0;(2OH)

HexCer 18:0;3O/21:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 15:0;3O/24:0;(2OH)

HexCer 15:0;3O/24:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 21:0;3O/18:0;(2OH)

HexCer 21:0;3O/18:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 20:0;3O/19:0;(2OH)

HexCer 20:0;3O/19:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 26:0;3O/13:0;(2OH)

HexCer 26:0;3O/13:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 23:0;3O/16:0;(2OH)

HexCer 23:0;3O/16:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 27:0;3O/12:0;(2OH)

HexCer 27:0;3O/12:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 14:0;3O/25:0;(2OH)

HexCer 14:0;3O/25:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 24:0;3O/15:0;(2OH)

HexCer 24:0;3O/15:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 22:0;3O/17:0;(2OH)

HexCer 22:0;3O/17:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 19:0;3O/20:0;(2OH)

HexCer 19:0;3O/20:0;(2OH)

C45H89NO10 (803.6486)


   

HexCer 25:0;3O/14:0;(2OH)

HexCer 25:0;3O/14:0;(2OH)

C45H89NO10 (803.6486)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] dotriacontanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] dotriacontanoate

C45H90NO8P (803.6404)


   

(3-Nonanoyloxy-2-octacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Nonanoyloxy-2-octacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

(2-Nonacosanoyloxy-3-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Nonacosanoyloxy-3-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

1,2-Diarachidoyl-sn-glycero-3-phosphoethanolamine

1,2-Diarachidoyl-sn-glycero-3-phosphoethanolamine

C45H90NO8P (803.6404)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecanoyloxypropan-2-yl] henicosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecanoyloxypropan-2-yl] henicosanoate

C45H90NO8P (803.6404)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] docosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] docosanoate

C45H90NO8P (803.6404)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] tricosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] tricosanoate

C45H90NO8P (803.6404)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] tetracosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] tetracosanoate

C45H90NO8P (803.6404)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] pentacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] pentacosanoate

C45H90NO8P (803.6404)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] hexacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] hexacosanoate

C45H90NO8P (803.6404)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] heptacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] heptacosanoate

C45H90NO8P (803.6404)


   

(3-Dodecanoyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Dodecanoyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

(2-Tetracosanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Tetracosanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

(3-Tetradecanoyloxy-2-tricosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Tetradecanoyloxy-2-tricosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

(2-Docosanoyloxy-3-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Docosanoyloxy-3-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

(2-Henicosanoyloxy-3-hexadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Henicosanoyloxy-3-hexadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

(2-Nonadecanoyloxy-3-octadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Nonadecanoyloxy-3-octadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

(3-Decanoyloxy-2-heptacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Decanoyloxy-2-heptacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

[(2S)-3-docosanoyloxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-docosanoyloxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] pentacosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] pentacosanoate

C45H90NO8P (803.6404)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hexadecanoyloxypropyl] tetracosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hexadecanoyloxypropyl] tetracosanoate

C45H90NO8P (803.6404)


   

[(2R)-2-hexacosanoyloxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-hexacosanoyloxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] hexacosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] hexacosanoate

C45H90NO8P (803.6404)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] pentacosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] pentacosanoate

C45H90NO8P (803.6404)


   

[(2R)-2-dodecanoyloxy-3-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-dodecanoyloxy-3-pentacosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] tricosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] tricosanoate

C45H90NO8P (803.6404)


   

[(2R)-2-tetradecanoyloxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-tetradecanoyloxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] hexacosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] hexacosanoate

C45H90NO8P (803.6404)


   

[(2R)-2-tetracosanoyloxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-tetracosanoyloxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

[(2R)-3-tetradecanoyloxy-2-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-tetradecanoyloxy-2-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

[(2S)-3-tetracosanoyloxy-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-tetracosanoyloxy-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] tricosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] tricosanoate

C45H90NO8P (803.6404)


   

[(2S)-3-henicosanoyloxy-2-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-henicosanoyloxy-2-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

[(2S)-3-hexacosanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-hexacosanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C45H90NO8P (803.6404)


   

PE-NMe(15:0/24:0)

PE-NMe(15:0/24:0)

C45H90NO8P (803.6404)


   

phosphatidylcholine 37:0

phosphatidylcholine 37:0

C45H90NO8P (803.6404)


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 37 carbons and no double bonds.

   

phosphatidylethanolamine 40:0

phosphatidylethanolamine 40:0

C45H90NO8P (803.6404)


A phosphatidylethanolamine in which the two acyl groups contain 40 carbon atoms and no double bonds.

   

phosphatidylethanolamine 40:0 zwitterion

phosphatidylethanolamine 40:0 zwitterion

C45H90NO8P (803.6404)


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 40 carbons in total with 0 double bonds.

   

MePC(36:0)

MePC(20:0_16:0)

C45H90NO8P (803.6404)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

dMePE(38:0)

dMePE(16:0_22:0)

C45H90NO8P (803.6404)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(2r)-n-[(2s,3s,4r)-3,4-dihydroxy-1-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadecan-2-yl]-2-hydroxydocosanimidic acid

(2r)-n-[(2s,3s,4r)-3,4-dihydroxy-1-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadecan-2-yl]-2-hydroxydocosanimidic acid

C45H89NO10 (803.6486)


   

(2r)-n-[(2s,3s,4r)-3,4-dihydroxy-15-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl]-2-hydroxydocosanimidic acid

(2r)-n-[(2s,3s,4r)-3,4-dihydroxy-15-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl]-2-hydroxydocosanimidic acid

C45H89NO10 (803.6486)


   

(2r)-n-[(2s,3s,4r)-3,4-dihydroxy-1-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl]-2-hydroxytricosanimidic acid

(2r)-n-[(2s,3s,4r)-3,4-dihydroxy-1-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl]-2-hydroxytricosanimidic acid

C45H89NO10 (803.6486)


   

n-(3,4-dihydroxy-14-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl)-2-hydroxydocosanimidic acid

n-(3,4-dihydroxy-14-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl)-2-hydroxydocosanimidic acid

C45H89NO10 (803.6486)


   

(2r)-n-[(2s,3s,4r)-3,4-dihydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl]-2-hydroxytricosanimidic acid

(2r)-n-[(2s,3s,4r)-3,4-dihydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl]-2-hydroxytricosanimidic acid

C45H89NO10 (803.6486)


   

n-(3,4-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadecan-2-yl)-2-hydroxydocosanimidic acid

n-(3,4-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadecan-2-yl)-2-hydroxydocosanimidic acid

C45H89NO10 (803.6486)


   

n-(3,4-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl)-2-hydroxytricosanimidic acid

n-(3,4-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl)-2-hydroxytricosanimidic acid

C45H89NO10 (803.6486)


   

(2r)-n-[(2s,3s,4r)-3,4-dihydroxy-15-methyl-1-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl]-2-hydroxydocosanimidic acid

(2r)-n-[(2s,3s,4r)-3,4-dihydroxy-15-methyl-1-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl]-2-hydroxydocosanimidic acid

C45H89NO10 (803.6486)


   

n-(3,4-dihydroxy-15-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl)-2-hydroxydocosanimidic acid

n-(3,4-dihydroxy-15-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl)-2-hydroxydocosanimidic acid

C45H89NO10 (803.6486)


   

(2r)-n-[(2s,3s,4r,14r)-3,4-dihydroxy-14-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl]-2-hydroxydocosanimidic acid

(2r)-n-[(2s,3s,4r,14r)-3,4-dihydroxy-14-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl]-2-hydroxydocosanimidic acid

C45H89NO10 (803.6486)